Risk factors and impact of β-D glucan on invasive fungal infection for the living donor liver transplant recipients

Tohoku Journal of Experimental Medicine

Volumn 209, Issue 3, 2006, Pages 207-215

  Kawagishi, Naoki ^a   Satoh, Kazushige ^a   Enomoto, Yoshitaka ^a   Akamatsu, Yorihiro ^a   Sekiguchi, Satoshi ^a   Fujimori, Keisei ^a   Satomi, Susumu ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

D glucan; Complication; Invasive fungal infection; Living donor liver transplantation; Risk factor

Indexed keywords

AMPHOTERICIN B; AZATHIOPRINE; BETA GLUCAN; COTRIMOXAZOLE; CYCLOSPORIN A; FLUCONAZOLE; FLUCYTOSINE; KANAMYCIN; METHYLPREDNISOLONE; MICAFUNGIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PSEUDOMONIC ACID; TACROLIMUS; VANCOMYCIN;

ADOLESCENT; ADULT; BLOOD LEVEL; CANDIDA ALBICANS; CHILD; CONTROLLED STUDY; EARLY DIAGNOSIS; FATALITY; FEMALE; FUNGUS CULTURE; FUNGUS ISOLATION; HEMOFILTRATION; HEPATIC VEIN; HUMAN; INFANT; INFECTION RISK; KIDNEY FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MYCOSIS; PLASMAPHERESIS; PNEUMOCYSTIS PNEUMONIA; RADIODIAGNOSIS; RECIPIENT; RESPIRATORY FAILURE; REVIEW; RISK ASSESSMENT; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; BETA-GLUCANS; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATIC VEINS; HUMANS; INFANT; KIDNEY FAILURE; LIVER DISEASES; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; MYCOSES; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 33745188678     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.209.207     Document Type: Review

References (26)

1. Aikawa, N., Sumiyama, Y., Kusachi, S., Hirasawa, H., Oda, S. & Yamazaki, Y. (2002) Use of antifungal agents in febrile patients nonresponsive to antibacterial treatment: the current status in surgical and critical care patients in Japan. J. Infect. Chemother., 8, 237-241.
2. Arnow, P.M., Carandang, G.C., Zabner, R. & Irwin, M.E. (1996) Randomized controlled trial of selective bowel decontamination for prevention of infections following liver transplantation. Clin. Infect. Dis., 22, 997-1003.
3. Avery, R.K. (2001) Fungal infection in the organ transplant recipient. Curr. Opin. Organ. Transplant., 6, 284-289.
4. Fortun, J., Martin-Davila, P., Moreno, S., De Vicente, E., Nuno, J., Candelas, A., Barcena, R. & Garcia, M. (2002) Risk factors for invasive aspergillosis in liver transplant recipients. Liver Transpl., 8, 1065-1070.
5. Gladdy, R.A., Richardson, S.E., Davies, H.D. & Sperina, R.A. (1999) Candida infection in pediatric liver transplant recipients. Liver Transpl. Surg., 5, 16-24.
6. Kato, A., Takita, T., Furuhashi, M., Takahashi, T., Maruyama, Y. & Hishida, A. (2001) Elevation of blood (1→3)-beta-D-glucan concentrations in hemodialysis patients. Nephron, 89, 15-19.
7. Kawagishi, N., Fujimori, K. & Satomi, S. (2004) Diagnosis and management of postoperative fungal infection in recipients of living donor liver transplantation. J. Abdom. Emerg. Med., 24, 57-65.
8. Matsumoto, C.S., Fishbein, T.M. & Kaufman, S.S. (2004) Gastrointestinal infection in solid organ transplan recipients. Curr. Opin. Organ. Transplant., 9, 406-410.
9. Miyazaki, T., Kohno, S., Mitsutake, K., Maesaki, S., Tanaka, K., Ishikawa, N. & Hara, K. (1995) Plasma (1→3)-beta-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis. J. Clin. Microbio., 33, 3115-3118.
10. Nakao, A., Yasui, M., Kawagoe, T., Tamura, H., Tanaka, S. & Takagi, H. (1997) False-positive endotoxemia derives from gauze glucan after hepatectomy for hepatocellular carcinoma with cirrhosis. Hepatogastroenterology, 44, 1413-1418.
11. Nieto-Rodriguez, J.A., Kusne, S., Manez, R., Irish, W., Linden, P., Magnone, M., Wing, E.J., Fung, J.J. & Starzl, T.E. (1996) Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients. Ann. Surgery, 223, 70-76.
12. Obayashi, T., Yoshida, M., Mori, T., Goto, H., Yasuoka, A., Iwasaki, H., Teshima, H., Kohno, S., Horiuchi, A. & Ito, A. (1995) Plasma (1→3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet, 345, 17-20.
13. Odabasi, Z., Mattiuzzi, G., Estey, E., Kantarjian, H., Saeki, F., Ridge, R.J., Ketchum, P.A., Finkelman, M.A., Rex, J.H. & Ostrosky-Zeichner, L. (2004) Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin. Infect. Dis., 39, 199-205.
14. Ostrosky-Zeichner, L., Alexander, B.D., Kett, D.H., Vazquez, J., Pappas, P.G., Saeki, F., Ketchum, P.A., Wingard, J., Schiff, R., Tamura, H., Finkelman, M.A. & Rex, J.H. (2005) Multicenter clinical evaluation of the (1-3)beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin. Infect. Dis., 41, 654-659.
15. Patel, R., Portela, D., Badley, A.D., Harmsen, W.S., Larson-Keller, J.J., Ilstrup, D.M., Keating, M.R., Wiesner, R.H., Krom, R.A. & Paya, C.V. (1996) Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation. Transplantation, 62, 926-934.
16. Paya, C.V. (2001) Prevention of fungal and hepatitis virus infections in liver transplantation. Clin. Infect. Dis., 33, S47-S52.
17. Pazos, C., Ponton, J. & Del Palacio, A. (2005) Contribution of (1→3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J. Clin. Microbiol., 43, 299-305.
18. Rabkin, J.M., Oroloff, S.L., Corless, C.L., Benner, K.G., Flora, K.D., Rosen, H.R. & Olyaei, A.J. (2000) Association of fungal infection and increased mortality in liver transplant recipients. Am. J. Surg., 179, 426-430.
19. Sakai, T., Ikegami, K., Yoshinaga, E., Uesugi-Hayakawa, R. & Wakizaka, A. (2000) Rapid, sensitive and simple detection of candida deep mycosis by amplification of 18S ribosomal RNA gene; comparison with assay of serum β-D-glucan level in clinical samples. Tohoku J. Exp. Med., 190, 119-128.
20. Singh, N., Gayowski, T., Wagener, M.M., Doyle, H. & Marino, I.R. (1997) Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent. Clin. Infect. Dis., 24, 179-184.
21. Singh, N., Wagener, M.M., Marino, I.R. & Gayowski, T. (2002) Trends in invasive fungal infections in liver transplant recipients: correlation with evolution in transplantation practices. Transplantation, 73, 63-67.
22. Suzuki, T., Hashimoto, T., Nakamura, T., Kondo, S., Shimizu, Y., Nakamura, Y., Hayashi, S., Itoh, K. & Manabe, T. (2000) Fungal infection in living related liver transplantation patients. Transplant. Proc., 32, 2231-2232.
23. Takakura, S., Fujihara, N., Saito, T., Kudo, T., Iinuma, Y. & Ichiyama, S. (2004) Naotional surveillance of species distribution in blood isolates of Candid speices in Japan and their susceptibility to six antifungal agents including voriconazol and micafungin. J. Antimicrobial. Chemotherapy., 53, 283-289.
24. van der Waaij, D. (1982) Colonization resistance of the digestive tract: clinical consequences and implications. J. Antimicrob. Chemother., 10, 263-270.
25. Verma, A., Wade, J.J., Cheeseman, P., Samaroo, B., Rela, M., Heaton, N.D., Mieli-Vergani, G. & Dhawan, A. (2005) Risk factors for fungal infection in paediatric liver transplant recipients. Pediatr. Transplant., 9, 220-225.
26. Wiesner, R.H., Hermans, P.E., Rakela, J., Washington, J.A., Perkins, J.D., DiCecco, S. & Krom, R. (1988) Selective bowel decontamination to decrease gram-negative aerobic bacterial and Candida colonization and prevent infection after orthotopic liver transplantation. Transplantation, 45, 570-574.